Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjane.2014.08.008
Brazilian Journal of Anesthesiology
Clinical Informations

Successful use of sugammadex for caesarean section in a patient with myasthenia gravis

O uso bem-sucedido de sugamadex para cesariana em paciente com miastenia grave

Lokman Soyoral; Ugur Goktas; Muhammed Bilal Cegin; Volkan Baydi

http://dx.doi.org/10.1016/j.bjane.2014.08.008 Braz J Anesthesiol, vol.67, n2, p.221-222, 2017
PDF English
PDF Português
Downloads: 0
Views: 622

Abstract

Abstract Myasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fluctuates, worsening with exertion, and improving with rest. Diagnosis of myasthenia gravis is made following clinical and physical examination and is confirmed by serum immunoassays to measure autoantibody levels. Myasthenia gravis especially when associated with pregnancy is a high-risk disease, and its course is unpredictable. We described the second report about use of sugammadex after rocuronium for a caesarean delivery with myasthenia gravis, but, unlike our case that formerly was diagnosed with myasthenia gravis, the patient was extubated on postoperative successfully and we did not encounter any respiratory problems.

Keywords

Myasthenia gravis, Sugammadex, Pregnancy

Resumo

Resumo Miastenia grave (MG) é uma doença autoimune caracterizada por fraqueza muscular que flutua, piora com o esforço físico e melhora com o repouso. O diagnóstico de MG é feito após exame clínico e físico e confirmado por imunoensaios séricos para medir os níveis de autoanticorpos. MG, especialmente quando associada à gravidez, é uma doença de alto risco e de curso imprevisível. Descrevemos o segundo relato sobre o uso de sugamadex após rocurônio para uma cesariana com miastenia grave, mas, ao contrário de nosso caso, que foi previamente diagnosticado com miastenia grave, a paciente foi extubada com sucesso no pós-operatório sem qualquer problema respiratório.

Palavras-chave

Miastenia grave, Sugammadex, Gravidez

References

Gilhus NE, Owe JF, Hoff JM. Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis. 2011;10:1-6.

Ferrero S, Esposito F, Biamonti M. Myasthenia gravis during pregnancy. Expert Rev Neurother. 2008;8:979-88.

Ferrero S, Pretta S, Nicoletti A. Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol. 2005;121:129-38.

Buckley C, Douek D, Newsom-Davis J. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol. 2001;50:64-72.

Qi QW, Wang D, Liu JT. Management of pregnancy with myasthenia gravis: 7 cases report. Zhonghua Fu Chan Ke Za Zhi. 2012;47:241-4.

Garcia V, Diemunsch P, Boet S. Use of rocuronium and sugammadex for caesarean delivery in a patient with myasthenia gravis. Int J Obstet Anesth. 2012;21:286-7.

Schaller SJ, Fink H. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core Evid. 2013;8:57-67.

Mundada SD, Shah B, Atram S. Emergency cesarean section in a patient of myasthenia gravis: is neuraxial anesthesia safe?. Saudi J Anaesth. 2012;6:430-1.

Berlit S, Tuschy B, Spaich S. Myasthenia gravis in pregnancy: a case report. Case Rep Obstet Gynecol. 2012;2012:736024.

5dcd947d0e88259a35bf58f3 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections